MY106921A - Novel cyclosporins - Google Patents

Novel cyclosporins

Info

Publication number
MY106921A
MY106921A MYPI93000352A MYPI19930352A MY106921A MY 106921 A MY106921 A MY 106921A MY PI93000352 A MYPI93000352 A MY PI93000352A MY PI19930352 A MYPI19930352 A MY PI19930352A MY 106921 A MY106921 A MY 106921A
Authority
MY
Malaysia
Prior art keywords
cyclosporins
amino
novel cyclosporins
novel
2alkyl
Prior art date
Application number
MYPI93000352A
Other languages
English (en)
Inventor
Reto Naef Dr
Karl Eberle Marcel
Trevor Glyn Payne Dr
Jakob Boelsterli Johann
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MY106921A publication Critical patent/MY106921A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Gasification And Melting Of Waste (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MYPI93000352A 1992-03-02 1993-02-26 Novel cyclosporins MY106921A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929204466A GB9204466D0 (en) 1992-03-02 1992-03-02 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
MY106921A true MY106921A (en) 1995-08-30

Family

ID=10711333

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI93000352A MY106921A (en) 1992-03-02 1993-02-26 Novel cyclosporins

Country Status (26)

Country Link
US (1) US5643870A (show.php)
EP (1) EP0577544B1 (show.php)
JP (1) JP3382656B2 (show.php)
KR (1) KR100256988B1 (show.php)
CN (1) CN1037104C (show.php)
AT (1) ATE146484T1 (show.php)
AU (1) AU667072B2 (show.php)
CA (1) CA2090634C (show.php)
CZ (1) CZ285421B6 (show.php)
DE (1) DE69306670T2 (show.php)
DK (1) DK0577544T3 (show.php)
ES (1) ES2096262T3 (show.php)
FI (1) FI111729B (show.php)
GB (1) GB9204466D0 (show.php)
GR (1) GR3022539T3 (show.php)
HU (1) HU214028B (show.php)
IL (1) IL104891A (show.php)
MX (1) MX9301129A (show.php)
MY (1) MY106921A (show.php)
NO (1) NO310685B1 (show.php)
NZ (1) NZ247031A (show.php)
PL (1) PL174816B1 (show.php)
RU (1) RU2131883C1 (show.php)
SK (1) SK279529B6 (show.php)
TW (1) TW264472B (show.php)
ZA (1) ZA931491B (show.php)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639852A (en) * 1994-09-01 1997-06-17 Wisconsin Alumni Research Foundation Immunostimulatory agents
CN1130373C (zh) * 1996-09-13 2003-12-10 诺瓦蒂斯有限公司 [3'－脱氧－3'－氧代－MeBmt]'环孢菌素制备方法
ZA9711732B (en) 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
JP4261049B2 (ja) 1997-10-08 2009-04-30 アイソテクニカ インコーポレイテッド 重水素化シクロスポリンアナログおよび免疫調節剤としてのそれらの使用
RU2235554C2 (ru) * 1998-03-06 2004-09-10 Новартис Аг Предварительно приготовленные эмульсионные концентраты, содержащие циклоспорин или макролид
US6784156B2 (en) * 2001-03-05 2004-08-31 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of respiratory diseases
EP1379547B1 (fr) * 2001-04-20 2005-12-21 Debiopharm S.A. Cyclosporine modifiee utilisable en tant que pro-drogue et son utilisation
US20030087813A1 (en) * 2001-10-12 2003-05-08 Or Yat Sun Cyclosporin analogs for the treatment of lung diseases
US6809077B2 (en) * 2001-10-12 2004-10-26 Enanta Pharmaceuticals, Inc. Cyclosporin analogs for the treatment of autoimmune diseases
PL210697B1 (pl) * 2001-10-19 2012-02-29 Isotechnika Inc Kompozycja zawierająca mieszaninę izomerów analogu cyklosporyny i zastosowanie tej mieszaniny
EP1436321B9 (en) * 2001-10-19 2008-11-12 Isotechnika Inc. Synthesis of cyclosporin analogs
US7012065B2 (en) * 2003-02-07 2006-03-14 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of immune disorders
JP2006524232A (ja) * 2003-03-17 2006-10-26 アルバニー モレキュラー リサーチ インコーポレーティッド 新規サイクロスポリン
US20040266669A1 (en) * 2003-06-20 2004-12-30 Wu Frank X. H. Cyclosporin derivatives for the treatment of immune disorders
JP2006014722A (ja) * 2004-06-02 2006-01-19 Keio Gijuku 遺伝子マーカー及びその利用
WO2006039164A2 (en) * 2004-09-29 2006-04-13 Amr Technology, Inc. Novel cyclosporin analogues and their pharmaceutical uses
WO2006039163A2 (en) * 2004-09-29 2006-04-13 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
EP1812037A4 (en) * 2004-10-06 2009-11-11 Amr Technology Inc ALKYNES OF CYCLOSPORINE AND THEIR USEFUL AS PHARMACEUTICAL AGENTS
US7696167B2 (en) * 2004-11-22 2010-04-13 Astellas Pharma Inc. Cyclic peptide compound
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
CA3014633C (en) 2007-10-08 2022-05-17 Aurinia Pharmaceuticals Inc. Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors
BRPI0911709A2 (pt) * 2008-07-30 2017-06-20 Isotechnika Labs Inc composto, processo para a produção de um composto, composição farmacêutica e método de tratar uma doença mediada a ciclofilina em um mamífero
WO2010144194A1 (en) 2009-06-09 2010-12-16 Lux Biosciences, Inc. Topical drug delivery systems for ophthalmic use
US20130267460A1 (en) * 2010-09-16 2013-10-10 The Johns Hopkins University Methods of Inhibiting Alphavirus Replication and Treating Alphavirus Infection
AU2011342284C1 (en) 2010-12-15 2017-07-13 Contravir Pharmaceuticals, Inc. Cyclosporine analogue molecules modified at amino acid 1 and 3
CN105076117B (zh) * 2014-10-31 2017-08-25 北京林业大学 一种种子抗老化剂及其制备方法
KR20170000243U (ko) 2015-07-09 2017-01-18 (주)하나피앤씨 배관연결용 플랜지 기구
US9981041B2 (en) * 2016-08-23 2018-05-29 Ira Jason Salzman Ophthalmic lubricating spray
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
EP0194972B1 (en) * 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4764503A (en) * 1986-11-19 1988-08-16 Sandoz Ltd. Novel cyclosporins
EP0283801A3 (en) * 1987-03-27 1990-05-30 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
ATE95193T1 (de) * 1987-06-17 1993-10-15 Sandoz Ag Cyclosporine und deren benutzung als arzneimittel.
GB8717300D0 (en) * 1987-07-22 1987-08-26 Nat Res Dev Cyclosporins
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
DE3840354A1 (de) * 1988-11-30 1990-06-07 Hoechst Ag Benzolsulfonamid-derivate und verfahren zu ihrer herstellung
WO1990006763A1 (en) * 1988-12-05 1990-06-28 The Trustees Of Columbia University In The City Of New York Novel derivatives of cyclosporine a, antibodies directed thereto and uses thereof
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
GB8916901D0 (en) * 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
FI111730B (fi) * 1990-11-02 2003-09-15 Novartis Ag Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi

Also Published As

Publication number Publication date
JPH07252296A (ja) 1995-10-03
DE69306670D1 (de) 1997-01-30
ATE146484T1 (de) 1997-01-15
CZ285421B6 (cs) 1999-08-11
PL297902A1 (en) 1993-09-06
CN1037104C (zh) 1998-01-21
GB9204466D0 (en) 1992-04-15
KR930019692A (ko) 1993-10-18
IL104891A (en) 1997-04-15
SK14093A3 (en) 1993-10-06
FI111729B (fi) 2003-09-15
AU3387293A (en) 1993-09-09
CA2090634C (en) 2005-12-13
NO310685B1 (no) 2001-08-13
TW264472B (show.php) 1995-12-01
CN1076453A (zh) 1993-09-22
ZA931491B (en) 1994-09-02
EP0577544B1 (en) 1996-12-18
MX9301129A (es) 1994-07-29
AU667072B2 (en) 1996-03-07
NO930738D0 (no) 1993-03-01
DE69306670T2 (de) 1997-07-03
JP3382656B2 (ja) 2003-03-04
DK0577544T3 (da) 1997-04-01
US5643870A (en) 1997-07-01
ES2096262T3 (es) 1997-03-01
CZ30393A3 (en) 1994-02-16
NZ247031A (en) 1995-05-26
RU2131883C1 (ru) 1999-06-20
EP0577544A1 (en) 1994-01-05
HU214028B (en) 1997-12-29
FI930912A0 (fi) 1993-03-01
HU9300418D0 (en) 1993-05-28
HUT64567A (en) 1994-01-28
PL174816B1 (pl) 1998-09-30
GR3022539T3 (en) 1997-05-31
SK279529B6 (sk) 1998-12-02
NO930738L (no) 1993-09-03
KR100256988B1 (ko) 2000-05-15
CA2090634A1 (en) 1993-09-03
FI930912L (fi) 1993-09-03
IL104891A0 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
MY106921A (en) Novel cyclosporins
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
MX9702380A (es) Nuevas carboxamidas con actividad antifungica.
MX9707570A (es) Utilizacion de agonistas de alta1l para el tratamiento de la incontinencia urinaria.
MX9605270A (es) Amidas de acidos tiocarboxilicos aromaticas substituidas.
UA32429C2 (uk) Засіб для лікування нетримання сечі
HU9400481D0 (en) New process for producing cetrorelix liophylizate
GB9305718D0 (en) Medicaments
CA2111083A1 (en) Novel peptides, their preparation and use
MX9707875A (es) Levobupivacaina y su uso como un anestesico en mujeres embarazadas.
DE59409704D1 (de) In den menschlichen körper einführbares instrument
HU9600727D0 (en) Triaryl-ethylene derivatives for use in therapy
ZA946008B (en) Novel tripeptides useful in immune and cns therapy
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
EP0647654A3 (show.php)
TW340108B (en) 1,1-difluoro-1,4-dichlorobutane and process for its preparation
MX9803953A (es) Peptidos novedosos, preparacion y uso de los mismos.
Zakroczymski et al. ABSORPTION OF HYDROGEN BY ION NITRIDED IRON
AU119820S (en) Resuscitator recoil bag
IT1255649B (it) Peptidi dotati di attivita' antibatterica
BG101119A (en) Analgesic composition
IT1263959B (it) N-acil-peptidi inibitori delle protein-chinasi
IT223743Z2 (it) Lettino abbronzante con gruppo lampade a bassa pressione per il corpo e gruppo lampade ad alta pressione per il viso
JO1657B1 (en) Gas cooler carporter
PL322847A1 (en) Condensed b-carbolins